SCHEMBL32688165

SCHEMBL32688165

N#Cc1c(-c2ccccc2C(=O)O)cc(=O)[nH]c1S

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ RECQL P46063 1/20 0.48
▸ FOLH1 Q04609 2/20 0.41
▸ BIRC5 O15392 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ IKBKB O14920 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20339404 0.79 ATM (0.58) KDM4ETDP1RECQLBIRC5PIM1
SCHEMBL32688042 0.76 ACMSD (0.52) KDM4ETDP1RECQLFOLH1ATM
SCHEMBL32688076 0.74 KDM4E (0.50) KDM4ETDP1RECQLBIRC5PIM1
SCHEMBL1343584 0.72 CYP3A4 (0.49) KDM4EFOLH1CYP3A4CYP2C9ALOX12
SCHEMBL32687996 0.71 KDM4E (0.43) KDM4ETDP1RECQLBIRC5PIM1
Water SCHEMBL27395300 0.71 ALDH1A1 (0.68) KDM4EFOLH1CYP3A4CYP2C9ALOX12
SCHEMBL10697723 0.71 CYP3A4 (0.47) FOLH1CYP3A4CYP2C9ALOX12ALDH1A1
SCHEMBL20340080 0.70 KDM4E (0.49) KDM4ETDP1RECQLALDH1A1KMT2A
SCHEMBL20339604 0.70 KDM4E (0.51) KDM4ETDP1RECQLBIRC5PIM1
SCHEMBL20350824 0.69 KDM4E (0.50) KDM4ETDP1RECQLPIM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KDM4E 3207/4885TDP1 1571/4885RECQL 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback